Pharma Reviews: The Donald Trump trade: A primer for the Indian stock investor

Valuations of the Indian pharma sector have corrected by 45 percent over the last 18 months, mainly on the back of regulatory issues and concerns of ...
Read more: The Donald Trump trade: A primer for the Indian stock investor